What if the most valuable longevity test isn’t the one that tells you you’re younger than your age — but the one that tells you your anti-aging strategy is going in the wrong direction?
That’s what made Jason Haxton’s experience with TruMe Labs so compelling. Over four rounds of testing across several years, he used TruMe not as a vanity metric, but as an objective feedback tool. And at one crucial moment, it helped reveal something unexpected: increasing a longevity intervention dramatically was not improving his biology — it was pushing it the other way.
